Ionis Pharmaceuticals IONS Deferred Tax Assets Leasing Arrangements
Deferred Tax Assets Leasing Arrangements at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:DeferredTaxAssetsLeasingArrangements.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's deferred tax assets leasing arrangements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's deferred tax assets leasing arrangements?
- Ionis Pharmaceuticals (IONS) reported deferred tax assets leasing arrangements of $71.87M in Q4 2025.
- What does deferred tax assets leasing arrangements mean?
- Future tax savings resulting from differences in how leases are treated for tax and accounting.
- How do you interpret deferred tax assets leasing arrangements?
- Changes generally track with the company's real estate or equipment leasing footprint.
- How does deferred tax assets leasing arrangements compare across companies?
- Standard across most capital-intensive industries with significant lease obligations.